Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Development and maintenance of the brain's immune toolkit: Microglia and non-parenchymal brain macrophages

  • López-Atalaya, José P.
  • Askew, Katharine E.
  • Sierra, Amanda
  • Gomez-Nicola, Diego
Microglia and non-parenchymal macrophages located in the perivascular space, the meninges and the choroid plexus are independent immune populations that play vital roles in brain development, homeostasis, and tissue healing. Resident macrophages account for a significant proportion of cells in the brain and their density remains stable throughout the lifespan thanks to constant turnover. Microglia develop from yolk sac progenitors, later evolving through intermediate progenitors in a fine-tuned process in which intrinsic factors and external stimuli combine to progressively sculpt their cell type-specific transcriptional profiles. Recent evidence demonstrates that non-parenchymal macrophages are also generated during early embryonic development. In recent years, the development of powerful fate mapping approaches combined with novel genomic and transcriptomic methodologies have greatly expanded our understanding of how brain macrophages develop and acquire specialized functions, and how cell population dynamics are regulated. Here, we review the transcription factors, epigenetic remodeling, and signaling pathways orchestrating the embryonic development of microglia and non-parenchymal macrophages. Next, we describe the dynamics of the macrophage populations of the brain and discuss the role of progenitor cells, to gain a better understanding of their functions in the healthy and diseased brain., Contract grant sponsor: Spanish Ministry of Economy and Competitiveness (MINECO) with European Regional Develop-ment Fund (ERDF) funds; contract grant numbers: BFU2015-66689, RYC-2013-12817.Contract grant sponsor: BBVA Foundation and a Basque Government; contract grant number: PI_2016_1_0011.Contract grant sponsor: “Ramon y Cajal” and European Social Fund (ESF) and national resources (MINEICO-AEI); contractgrant number: RYC-2015-18056.Contract grant sponsor: MINECO co-financed by the EuropeanRegional Development Fund (ERDF); contract grant number:SAF2014-60233-JIN.Contract grant sponsor: Instituto de Neurociencias is a “Centre ofExcellence Severo Ochoa”; contract grant number: SEV-2013-0317.Contract grant sponsor: Medical Research Council, Alzheimer’s Research UK and The Leverhulme Trust., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Lack of IL-1r8 in neurons causes hyperactivation of IL-1 receptor pathway and induces MECP2-dependent synaptic defects

  • Tomasoni, Romana
  • Morini, Raffaella
  • López-Atalaya, José P.
  • Corradini, Irene
  • Canzi, Alice
  • Rasile, Marco
  • Mantovani, Cristina
  • Pozzi, Davide
  • Garlanda, Cecilia
  • Mantovani, Alberto
  • Menna, Elisabetta
  • Barco, Ángel
  • Matteoli, Michela
Inflammation modifies risk and/or severity of a variety of brain diseases through still elusive molecular mechanisms. Here we show that hyperactivation of the interleukin 1 pathway, through either ablation of the interleukin 1 receptor 8 (IL-1R8, also known as SIGIRR or Tir8) or activation of IL-1R, leads to up-regulation of the mTOR pathway and increased levels of the epigenetic regulator MeCP2, bringing to disruption of dendritic spine morphology, synaptic plasticity and plasticity-related gene expression. Genetic correction of MeCP2 levels in IL-1R8 KO neurons rescues the synaptic defects. Pharmacological inhibition of IL-1R activation by Anakinra corrects transcriptional changes, restores MeCP2 levels and spine plasticity and ameliorates cognitive defects in IL-1R8 KO mice. By linking for the first time neuronal MeCP2, a key player in brain development, to immune activation and demonstrating that synaptic defects can be pharmacologically reversed, these data open the possibility for novel treatments of neurological diseases through the immune system modulation., Work in our lab is supported by Cariplo 2012–0560, Ministero della Salute GR-2011–02347377, CARIPLO 2015–0594, to MM and by Cariplo 2015–0952 to RT. RT was previously supported by a Fondazione Umberto Veronesi Fellowship. IC is supported by a Fondazione Giancarla Vollaro Fellowship. JPLA is supported by grant SAF2014-60233-JIN from the Ministerio de Economia y Competitividad (MINECO) co-financed by the European Regional Development Fund (ERDF). AB is supported by grants SAF2014-56197-R, SEV-2013-0317 and PCIN-2015-192-C02-01 from MINECO co-financed by the European Regional Development Fund (ERDF). AM acknolewledges a grant from Fondazione Cariplo (Contract n. 2015- 0564., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Loss of Kdm5c causes spurious transcription and prevents the fine-tuning of activity-regulated enhancers in neurons

  • Scandaglia, Marilyn
  • López-Atalaya, José P.
  • Medrano-Fernandez, Alejandro
  • López-Cascales, María Teresa
  • Blanco, Beatriz del
  • Lipinski, Michal
  • Benito, Eva
  • Olivares, Román
  • Iwase, Shigeki
  • Shi, Yang
  • Barco, Ángel
During development, chromatin-modifying enzymes regulate both the timely establishment of cell-type-specific gene programs and the coordinated repression of alternative cell fates. To dissect the role of one such enzyme, the intellectual-disability-linked lysine demethylase 5C (Kdm5c), in the developing and adult brain, we conducted parallel behavioral, transcriptomic, and epigenomic studies in Kdm5c-null and forebrain-restricted inducible knockout mice. Together, genomic analyses and functional assays demonstrate that Kdm5c plays a critical role as a repressor responsible for the developmental silencing of germline genes during cellular differentiation and in fine-tuning activity-regulated enhancers during neuronal maturation. Although the importance of these functions declines after birth, Kdm5c retains an important genome surveillance role preventing the incorrect activation of non-neuronal and cryptic promoters in adult neurons., M.S. and A.M.-F. are recipients of “Formación de Personal Investigador” fellowships, and B.d.B. is the recipient of a “Juan de la Cierva – Incorporación” contract (all from the Spanish Ministry of Economy and Competitivity [MINECO]). J.P.L.-A.’s research is supported by a “Ramón y Cajal” contract and by grant SAF2014-60233-JIN from MINECO (co-financed by the European Regional Development Fund [ERDF]). A.B.’s research is supported by grants SAF2014-56197-R, PCIN-2015-192-C02-01 (part of the coordinated project ERA-Net NEURON8-2015), and SEV-2013-0317 from MINECO (co-financed by ERDF), grant PROMETEO/2016/006 from the Generalitat Valenciana, a NARSAD Independent Investigator grant (no. 21941) from the Brain & Behavior Research Foundation, and a grant from the Alicia Koplowitz Foundation. S.I.’s research is supported by NIH grant NS089896 and the Farrehi Family Foundation. KDM5C research in the Y.S. lab is supported by NIH grant MH096066. Y.S. is an American Cancer Society Research Professor. The Instituto de Neurociencias is a “Centre of Excellence Severo Ochoa.”, Peer reviewed